Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
10 studies found for:    17982182 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Role of the P2Y12 Receptor in Tissue Factor Induced Coagulation
Conditions: Healthy Volunteers;   Sepsis
Interventions: Drug: Prasugrel;   Drug: Placebo
2 Not yet recruiting Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors Therapy
Conditions: Acute Coronary Syndrome;   Platelet Reactivity on Novel P2Y12 Inhibitors With and Without Aspirin
Intervention: Drug: Aspirin
3 Recruiting Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing
Condition: Coronary Heart Disease
Interventions: Drug: Ticagrelor;   Drug: Prasugrel
4 Unknown  Plavix, Prasugrel and Drug Eluting Stents Pilot Trial
Conditions: Coronary Artery Disease;   Platelet Aggregation Inhibitors;   PCI- Percutaneous Coronary Intervention
Interventions: Drug: Loading Dose Arm;   Drug: Maintenance Dose Arm
5 Completed
Has Results
A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention
Conditions: Coronary Arteriosclerosis;   Acute Coronary Syndromes
Interventions: Drug: Prasugrel;   Drug: Clopidogrel
6 Recruiting CARDIOBASE Bern PCI Registry
Condition: Myocardial Ischemia
Intervention: Procedure: Percutaneous coronary intervention
7 Not yet recruiting Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention
Conditions: Cardiovascular Disease;   Interventional Cardiology
Interventions: Drug: Aspirin;   Drug: Placebo;   Drug: ticagrelor
8 Enrolling by invitation P2Y12 Inhibitors Utilization in Bifurcation and Chronic Total Occlusion PCI
Condition: Coronary Arteriosclerosis
Intervention:
9 Completed Effect of Prasugrel Versus Clopidogrel on Platelet Function After Bivalirudin Cessation
Condition: Coronary Artery Disease
Interventions: Drug: Prasugrel;   Drug: Clopidogrel
10 Terminated Genotype Guided Comparison of Clopidogrel and Prasugrel Outcomes Study
Condition: Cardiovascular Disease
Intervention:

Indicates status has not been verified in more than two years